Filter
2732
Filtered Results: 2732
Text search:
vector
Featured
Recommendations
237
New Publications
764
Language
Document type
No document type
1332
Studies & Reports
578
Guidelines
360
Strategic & Response Plan
138
Manuals
136
Fact sheets
76
Training Material
43
Situation Updates
23
Resource Platforms
17
Infographics
13
Brochures
9
Videos
3
Dashboards/Maps
2
Online Courses
2
Countries / Regions
Global
168
Latin America and the Carribbean
104
Indonesia
68
India
66
Brazil
65
Kenya
53
Sierra Leone
43
Uganda
42
Ethiopia
40
Africa
39
Mozambique
38
Venezuela
36
Liberia
36
Western and Central Europe
34
Congo, Democratic Republic of
33
Paraguay
32
Colombia
31
Senegal
31
Nepal
30
Nigeria
30
Malawi
30
Tanzania
30
Ghana
28
Germany
27
Zambia
26
Rwanda
25
Bolivia
23
Argentina
23
Myanmar / Burma
22
Bangladesh
21
South Africa
21
Zimbabwe
16
Philippines
16
South–East Asia Region
16
Madagascar
15
South Sudan
14
Guinea
13
Namibia
13
Benin
12
Burkina Faso
12
Peru
12
West and Central Africa
12
East and Southern Africa
12
Ukraine
11
Haiti
11
Angola
11
Cameroon
10
North America
10
Syria
9
Eastern Europe
9
Chile
8
Asia
8
Russia
8
Somalia
8
Middle East and North Africa
7
Sudan
7
Botswana
7
Pakistan
7
El Salvador
6
Cambodia
6
Eastern Europe and Central Asia
6
Mali
6
Chad
6
Yemen
5
Eswatini/ Swaziland
5
Lesotho
4
Guinea-Bissau
4
Lebanon
4
Central African Republic
4
Ecuador
4
China
3
Albania
3
Laos
3
USA
3
Jordan
3
Western Pacific Region
3
Spain
3
Papua New Guinea
3
Honduras
3
Guatemala
3
Thailand
2
Mexico
2
Turkey
2
Togo
2
Iran
2
Niger
2
Afghanistan
2
Italy
2
Dominican Republic
2
Saudi Arabia
2
United Kingdom
2
Portugal
2
Bosnia and Herzegovina
2
Côte d’Ivoire / Ivory Coast
2
Vietnam
2
Palestine
2
Libya
2
Iraq
2
North Macedonia
1
Tajikistan
1
Timor Leste/ East Timor
1
Gambia
1
Singapore
1
Kyrgyzstan
1
Burundi
1
Vanuatu
1
Morocco
1
Qatar
1
Mauritania
1
Japan
1
France
1
Mauritius
1
Tunisia
1
Sri Lanka
1
Djibouti
1
Egypt
1
Romania
1
Greece
1
Georgia
1
Authors & Publishers
Publication Years
Category
Countries
1032
Clinical Guidelines
195
Public Health
191
Key Resources
174
Women & Child Health
91
Capacity Building
38
Pharmacy & Technologies
28
Toolboxes
NTDs
328
COVID-19
249
Planetary Health
235
Rapid Response
201
Zika
160
Mental Health
74
Global Health Education
73
Natural Hazards
72
Ebola & Marburg
69
TB
59
HIV
52
Caregiver
44
Refugee
43
Disability
39
Malaria
38
AMR
36
Conflict
34
Health Financing Toolbox
33
Pharmacy
23
NCDs
15
Specific Hazards
13
Cholera
10
Typhoon
4
Social Ethics
3
Polio
1
Parasites & Vectors volume 11, Article number: 264 (2018)
Dengue creates a staggering epidemiological and economic burden for endemic countries. Without a specific therapy and with a commercial vaccine that presents some problems relative to its full effectiveness, initiatives to improve vector...
Parasites & Vectors volume 15, Article number: 389 (2022)
Dengue is one of the common arboviral infections and is a public health problem in South East Asia. The aim of this systematic review and meta-analysis was to evaluate the prevalence and distribution of dengue in SAARC (South Asian Associ...
Parasites Vectors 14, 50 (2021). https://doi.org/10.1186/s13071-020-04555-8
Leishmaniasis is a vector-borne disease that is transmitted by sandflies and caused by obligate intracellular protozoa of the genus Leishmania. Human infection is caused by about 21 of 30 species that infect mammals. These include the L. donovani complex with 3 species (L. donovani, L. infantum, and...
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an...
Leishmaniasis is a complex vector-borne disease involving in its transmission several species of protozoan parasites called Leishmania, a wide variety of animal reservoirs and phlebotomine sandflies vectors. Cutaneous Leishmaniasis (CL) is the most common form of the disease, and its clinical manife...
Leishmaniasis is a vector-borne tropical/subtropical disease caused by an intracellular parasite transmitted to humans by sand fly bite. It is endemic in Asia, Africa, the Americas, and the Mediterranean region. Worldwide reports include 1.5–2 million new cases each year, more than 300 million at ...
Trypanosoma cruzi is the etiological agent of Chagas disease (CD), considered one of the most important parasitic infections in Latin America. Between 25 and 90 million humans are at infection risk via at least one of multiple infection mechanisms. Under natural conditions, the principal transmissio...
Due to the particular Amazonian situation of vectorial transmission based mostly on the wild cycle of Trypanosoma cruzi with diversity of triatomine vectors involved in effective transmission, and the variety of eco-epidemiological situations that facilitate such transmission, the countries of the A...
Human African trypanosomiasis (HAT) has been an alarming global public health issue. The disease affects mainly poor and marginalized people in low-resource settings and is caused by two subspecies of haemoflagellate parasite, Trypanosoma brucei and transmitted by tsetse flies. Progress made in HAT ...
Long-lasting insecticidal nets (LNs) constitute a core vector control intervention against malaria. A number of new LN products are under development and will require assessment of risks to humans. This document provides an updated generic model that can be used for the risk assessment of exposure t...
This project aimed to reduce the risk of vector-borne infection with Chagas disease by
controlling triatomine bugs, the vectors transmitting the parasite of Chagas disease, and
establishing an epidemiological surveillance system with community participation.
The school and a community teaching modules are aimed at preventing vector-borne diseases through community participation. Meanwhile, the interactive toolkit is meant to be help raise awareness on health, sanitation and vector control. These materials will help volunteers and practitioners foster di...
Cutaneous leishmaniasis (CL) is a parasitic disease caused by infection with a vector-borne protozoan parasite of the genus Leishmania spp. The parasite is transmitted by the bite of an infected phlebotomine sand fly. Infection results in skin lesions which take a long time to heal and may leave per...
The Onchocerciasis Control Programme in West Africa (OCP) undertook regional and large scale frght against onchocerciasis in West Africa in 1974 using a vector control strategy. By 2002 OCP had succeeded in eliminating the disease as a public health, socio-economic and development problem in 10 out ...
(Первинна та бустерна вакцинації) – з векторною вакциною – (вакцина Janssen® від COVID-19 виробництва Janssen Cilag International/Johnson & Johnson
Станом на: 14 лютого 2022 р. (даний інформаційн...
Policy Guidance Brief 2
• The potential health risks from climate change include: increase of waterborne and vector-borne diseases, heat-related illnesses, injuries and deaths, food insecurity and increased malnutrition. The poor, women, children and the elderly, as well as communities living...
• The potential health risks from climate change include: increase of waterborne and vector-borne diseases, heat-related illnesses, injuries and deaths, food insecurity and increased malnutrition. The poor, women, children and the elderly, as well as communities living...
Cutaneous leishmaniasis (CL) is a neglected infectious endemic disease that is transmitted through the bite of a vector insect (sandfly) of the Lutzomyia genus,typical of rural geographical territories, and causes disfiguring skin ulcers and disabilities. It is estimated that CL affects between 600 ...
Sleeping sickness is controlled by case detection and treatment but this often only reaches less than 75% of the population. Vector control is capable of completely interrupting HAT transmission but is not used because of expense. We conducted a full scale field trial of a refined vector control tec...
Enfermedad de Chagas e inmunosupresión. Decálogo para la prevención, el diagnóstico y el tratamiento
Según las estimaciones, en las Américas hay entre 6 y 8 millones de personas con infección por T. cruzi, con aproximadamente 30 000 casos nuevos por año por transmisión vectorial, y 8000 casos nuevos anuales por transmisión congénita. Es decir, cerca de 65 millones de personas viven en la Reg...
